Insmed (INSM)
(Delayed Data from NSDQ)
$71.69 USD
-1.17 (-1.61%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $72.05 +0.36 (0.50%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/27/25 |
---|---|
Current Quarter | -1.17 |
EPS Last Quarter | -1.27 |
Last EPS Surprise | -6.72% |
ABR | 1.00 |
Earnings ESP
|
0.46% |
---|---|
Current Year | -5.42 |
Next Year | -4.16 |
EPS (TTM) | -5.55 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 96.28M | 89.52M | 355.09M | 488.65M |
# of Estimates | 6 | 2 | 5 | 6 |
High Estimate | 99.34M | 93.43M | 358.61M | 637.26M |
Low Estimate | 92.00M | 85.60M | 351.00M | 400.30M |
Year ago Sales | 83.69M | 75.50M | 305.21M | 355.09M |
Year over Year Growth Est. | 15.04% | 18.56% | 16.34% | 37.61% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.17 | -1.13 | -5.42 | -4.16 |
# of Estimates | 7 | 3 | 9 | 8 |
Most Recent Consensus | -1.27 | -1.12 | -5.46 | -3.26 |
High Estimate | -1.05 | -1.06 | -5.29 | -3.12 |
Low Estimate | -1.27 | -1.20 | -5.68 | -4.71 |
Year ago EPS | -1.28 | -1.06 | -5.34 | -5.42 |
Year over Year Growth Est. | 8.59% | -6.60% | -1.50% | 23.26% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 0 | 4 | 4 |
Up Last 30 Days | 2 | 0 | 4 | 4 |
Up Last 60 Days | 3 | 0 | 5 | 5 |
Down Last 7 Days | 3 | 1 | 4 | 3 |
Down Last 30 Days | 3 | 1 | 4 | 3 |
Down Last 60 Days | 3 | 1 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.17 | -1.13 | -5.42 | -4.16 |
7 Days Ago | -1.22 | -1.09 | -5.42 | -4.28 |
30 Days Ago | -1.22 | -1.09 | -5.41 | -4.24 |
60 Days Ago | -1.23 | -1.04 | -5.42 | -4.25 |
90 Days Ago | -1.11 | NA | -4.98 | -3.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.16 | -1.12 | -5.44 | -4.11 |
Zacks Consensus Estimate | -1.17 | -1.13 | -5.42 | -4.16 |
Earnings ESP | 0.46% | 0.60% | -0.31% | 1.40% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.27 | -1.94 | -1.06 | -1.28 | NA |
Estimate | -1.19 | -1.22 | -1.22 | -1.13 | NA |
Difference | -0.08 | -0.72 | 0.16 | -0.15 | -0.20 |
Surprise | -6.72% | -59.02% | 13.11% | -13.27% | -16.48% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more